AbCellera to Participate at Upcoming Investor Conferences in March

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:

• 45th Annual TD Cowen Health Care Conference, March 3-5
• KeyBanc Capital Markets Healthcare Forum, March 18-19

Visit AbCellera's Investor Relations website for additional information.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250211013862/en/

Inquiries
Media: Tiffany Chiu; [email protected], +1(604)724-1242
Business Development: Murray McCutcheon, Ph.D.; [email protected], +1(604)559-9005
Investor Relations: Peter Ahn; [email protected], +1(778)729-9116

Source: AbCellera Biologics Inc.

You May Also Be Interested In

• Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
• The Crypto Bull Run Is Back and the Wallets Getting In Early Are Already Inside Pepeto
• 5 Best Crypto Presales as Upbit Adds Four Tokens and Fresh Listings Send Prices Jumping